Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).

Translated title of the contribution: Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).

Mackenzie MacDonald, I.S. MacKenzie, L. Wei, C.J. Hawkey, D.E. Grobbee, x Scot Study group collaborators, I. Ford

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionMethodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT).
Original languageUndefined/Unknown
Pages (from-to)e002295
Number of pages1
JournalBMJ open [E]
Volume29
Issue number3
DOIs
Publication statusPublished - 2013

Cite this